Jupiter Neurosciences Inc.

JUNS | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.98

+$0.11 (+3.83%)

At close: Sep 22, 2026, 4:00 PM ET

$3.10

+$0.12 (+4.03%)

After-hours: Sep 22, 2026, 7:58 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.83%

(1D)

Rating

Updated: Sep 18, 2026

31.8

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.44M

1D Range

2.88 3.38

52W Range

2.86 138

Valuation (TTM)

PE -0.15

PB -3.80

EV/EBITDA -0.17

Valuation (NTM)

Forward PE 17.75

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -521.2%

SBC Adj. FCF Yield -528.9%

SBC Impact -1.5%

Margins

Gross Margin 88.3%

Operating Margin -15166.7%

FCF Margin -11206.0%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | -42.5%

Dil EPS 3Y | 5Y -47.0% | 15.9%

FCF 3Y | 5Y -75.7% | -54.0%

Returns

ROA -247.4%

ROE 747.3%

ROIC -709.4%

Financial Health

Net Debt

$227.2K

Current Ratio 0.66

Interest Coverage -47.42

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main object...

Sector Healthcare

Industry Biotechnology

Employees 5

IPO Date Dec 2, 2024

Website jupiterneurosciences.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞